|Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.|
P Braitstein, MW Brinkhof, F Dabis, M Schechter, A Boulle, P Miotti, ...
Lancet 367 (9513), 817, 2006
|Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa|
D Coetzee, K Hildebrand, A Boulle, G Maartens, F Louis, V Labatala, ...
Aids 18 (6), 887-895, 2004
|Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies|
LF Johnson, J Mossong, RE Dorrington, M Schomaker, CJ Hoffmann, ...
PLoS Medicine 10 (4), e1001418, 2013
|Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries|
MWG Brinkhof, F Dabis, L Myer, DR Bangsberg, A Boulle, D Nash, ...
Bulletin of the World Health Organization 86, 559-567, 2008
|Task shifting of antiretroviral treatment from doctors to primary-care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster-randomised trial|
L Fairall, MO Bachmann, C Lombard, V Timmerman, K Uebel, ...
The Lancet 380 (9845), 889-898, 2012
|Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa|
A Boulle, G Van Cutsem, K Hilderbrand, C Cragg, M Abrahams, S Mathee, ...
Aids 24 (4), 563-572, 2010
|Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002–2007|
M Cornell, A Grimsrud, L Fairall, MP Fox, G van Cutsem, J Giddy, R Wood, ...
AIDS (London, England) 24 (14), 2263, 2010
|Outcomes of nevirapine-and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy|
A Boulle, G Van Cutsem, K Cohen, K Hilderbrand, S Mathee, M Abrahams, ...
Jama 300 (5), 530-539, 2008
|Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial|
MX Rangaka, RJ Wilkinson, A Boulle, JR Glynn, K Fielding, G van Cutsem, ...
The Lancet 384 (9944), 682-690, 2014
|Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes|
M May, A Boulle, S Phiri, E Messou, L Myer, R Wood, O Keiser, ...
The Lancet 376 (9739), 449-457, 2010
|Cohort Profile: The international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa|
M Egger, DK Ekouevi, C Williams, RE Lyamuya, H Mukumbi, P Braitstein, ...
International journal of epidemiology 41 (5), 1256-1264, 2012
|Gender Differences in Survival among Adult Patients Starting Antiretroviral Therapy in South Africa: A Multicentre Cohort Study|
M Cornell, M Schomaker, DB Garone, J Giddy, CJ Hoffmann, R Lessells, ...
PLoS Medicine 9 (9), e1001304, 2012
|Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality|
MWG Brinkhof, A Boulle, R Weigel, E Messou, C Mathers, C Orrell, ...
PLoS medicine 6 (4), e1000066, 2009
|Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration|
P Braitstein, A Boulle, D Nash, MWG Brinkhof, F Dabis, C Laurent, ...
Journal of women's health 17 (1), 47-55, 2008
|Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa|
A Boulle, MA Davies, H Hussey, M Ismail, E Morden, Z Vundle, ...
Clinical infectious diseases: an official publication of the Infectious …, 2020
|Effectiveness of antiretroviral treatment in a South African program: a cohort study|
LR Fairall, MO Bachmann, G Louwagie, C van Vuuren, P Chikobvu, ...
Archives of Internal Medicine 168 (1), 86, 2008
|Effectiveness of Patient Adherence Groups as a Model of Care for Stable Patients on Antiretroviral Therapy in Khayelitsha, Cape Town, South Africa|
MA Luque-Fernandez, G Van Cutsem, E Goemaere, K Hilderbrand, ...
PloS one 8 (2), e56088, 2013
|Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America|
O Keiser, K Anastos, M Schechter, E Balestre, L Myer, A Boulle, ...
Trop Med Int Health 13 (7), 870-879, 2008
|Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings|
M Forster, C Bailey, MWG Brinkhof, C Graber, A Boulle, M Spohr, ...
Bulletin of the World Health Organization 86, 939-947, 2008
|Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis|
O Ajose, S Mookerjee, EJ Mills, A Boulle, N Ford
AIDS 26 (8), 929, 2012